|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 59.00 NOK | -1.17% |
|
+0.17% | -17.37% |
| 09/06 | Photocure, Artera Enter Research Partnership for Bladder Cancer Diagnostics | MT |
| 09/06 | Photocure ASA and Artera Partner on Digital Pathology AI Test Evaluation for Bladder Cancer | CI |
| Market Cap | 156.98Cr 16Cr 14Cr 13Cr 12Cr 23Cr 1.56TCr 23Cr 154.33Cr 60Cr 762.78Cr 62Cr 61Cr 2.64TCr | P/E Ratio 2026 * |
19.3x | P/E Ratio 2027 * | 30.8x |
|---|---|---|---|---|---|
| Enterprise Value | 124.68Cr 13Cr 11Cr 10Cr 9.76Cr 18Cr 1.24TCr 18Cr 122.57Cr 48Cr 605.83Cr 49Cr 48Cr 2.09TCr | EV / Sales 2026 * |
1.97x | EV / Sales 2027 * | 1.78x |
| Free-Float |
94.52% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Photocure ASA
| 1 day | -1.17% | ||
| 1 week | +0.17% | ||
| Current month | -4.84% | ||
| 1 month | -6.50% | ||
| 3 months | -12.59% | ||
| 6 months | -12.07% | ||
| Current year | -17.37% |
| 1 week | 56.2 |  | 60.9 |
| 1 month | 56.2 | | 67.8 |
| Current year | 55.2 | | 79.8 |
| 1 year | 49.5 | | 79.8 |
| 3 years | 40.7 | | 79.8 |
| 5 years | 40.7 | | 146.5 |
| 10 years | 21.5 | | 154.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel Schneider
CEO | Chief Executive Officer | - | 01/11/2018 |
Erik Dahl
CEO | Chief Executive Officer | - | 01/07/2018 |
Anders Neijber
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Neal Shore
BRD | Director/Board Member | - | 01/01/2022 |
Dylan Hallerberg
CHM | Chairman | - | 27/09/2023 |
| Director/Board Member | - | 23/05/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02/25/02 | Buy | Company | 8,997 | 0.0332% | ||
| 02/25/02 | Buy | Company | 11,355 | 0.0419% | ||
| 31/25/31 | Buy | Company | 27,113 | 0.1000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.17% | +0.17% | +15.46% | +15.01% | 17Cr | |
| -0.32% | -0.18% | +37.83% | +152.24% | 1,01000Cr | |
| -2.16% | +1.24% | +50.01% | +45.87% | 58TCr | |
| -2.70% | -2.48% | +15.97% | +62.66% | 40TCr | |
| +0.77% | 0.00% | +21.28% | +19.14% | 33TCr | |
| -1.52% | +1.90% | +23.73% | +34.08% | 28TCr | |
| -1.95% | -4.75% | +20.15% | +14.68% | 28TCr | |
| -0.57% | +0.62% | -44.67% | -47.65% | 20TCr | |
| -1.31% | +0.27% | +18.74% | +57.70% | 19TCr | |
| -0.38% | -3.76% | +13.02% | +59.46% | 16TCr | |
| Average | -0.84% | +0.89% | +17.15% | +41.32% | 34.29TCr | |
| Weighted average by Cap. | -0.56% | +1.04% | +26.19% | +68.99% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63Cr 6.67Cr 5.74Cr 5.28Cr 4.96Cr 9.24Cr 631.55Cr 9.41Cr 62Cr 24Cr 308.31Cr 25Cr 24Cr 1.07TCr | 68Cr 7.1Cr 6.11Cr 5.62Cr 5.29Cr 9.84Cr 672.36Cr 10Cr 66Cr 26Cr 328.23Cr 27Cr 26Cr 1.13TCr |
| Net income | 8.15Cr 85.66L 73.77L 67.8L 63.77L 1.19Cr 81Cr 1.21Cr 8.01Cr 3.13Cr 40Cr 3.21Cr 3.15Cr 136.82Cr | 5.1Cr 53.61L 46.16L 42.43L 39.9L 74.31L 51Cr 75.65L 5.01Cr 1.96Cr 25Cr 2.01Cr 1.97Cr 86Cr |
| Net Debt | -32Cr -3.4Cr -2.92Cr -2.69Cr -2.53Cr -4.71Cr -321.5Cr -4.79Cr -32Cr -12Cr -156.95Cr -13Cr -12Cr -542.26Cr | -36Cr -3.84Cr -3.3Cr -3.04Cr -2.86Cr -5.32Cr -363.31Cr -5.41Cr -36Cr -14Cr -177.36Cr -14Cr -14Cr -612.77Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/26/15 | 59.00 kr | -1.17% | 33,481 |
| 12/26/12 | 59.70 kr | +3.11% | 50,507 |
| 11/26/11 | 57.90 kr | +0.87% | 31,364 |
| 10/26/10 | 57.40 kr | 0.00% | 1,02,319 |
| 09/26/09 | 57.40 kr | -1.37% | 60,795 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PHO Stock
Select your edition
All financial news and data tailored to specific country editions
